Neurobiology of Aging
Volume 31, Issue 3 , Pages 387-397 , March 2010

Functional compensation in incipient Alzheimer's disease

  • A. Caroli

      Affiliations

    • LENITEM Laboratory of Epidemiology, Neuroimaging, and Telemedicine, IRCCS San Giovanni di Dio-FBF, Brescia, Italy
    • Medical Imaging Unit, Biomedical Engineering Department, Mario Negri Institute for Pharmacological Research, Bergamo, Italy
    • ,
  • C. Geroldi

      Affiliations

    • LENITEM Laboratory of Epidemiology, Neuroimaging, and Telemedicine, IRCCS San Giovanni di Dio-FBF, Brescia, Italy
    • Psychogeriatrics Unit, IRCCS San Giovanni di Dio-FBF, Brescia, Italy
    • ,
  • F. Nobili

      Affiliations

    • Division of Clinical Neurophysiology, Department of Endocrinological and Medical Sciences, University of Genoa, Italy
    • ,
  • L.R. Barnden

      Affiliations

    • Department of Nuclear Medicine, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia
    • ,
  • U.P. Guerra

      Affiliations

    • Department of Nuclear Medicine, Ospedali Riuniti, Bergamo, Italy
    • ,
  • M. Bonetti

      Affiliations

    • Neuroradiology Service, Clinical Institute Città di Brescia, Brescia, Italy
    • ,
  • G.B. Frisoni

      Affiliations

    • LENITEM Laboratory of Epidemiology, Neuroimaging, and Telemedicine, IRCCS San Giovanni di Dio-FBF, Brescia, Italy
    • Psychogeriatrics Unit, IRCCS San Giovanni di Dio-FBF, Brescia, Italy
    • AFaR Associazione Fatebenefratelli per la Ricerca, Rome, Italy
    • Corresponding Author InformationCorresponding author at: Laboratory of Epidemiology, Neuroimaging and Telemedicine, IRCCS San Giovanni di Dio-FBF, via Pilastroni 4, 25125 Brescia, Italy. Tel.: +39 030 3501361; fax: +39 02 700435727.

Received 12 November 2007 ,Revised 27 March 2008 ,Accepted 1 May 2008.

References 

  1. Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, et al. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch. Neurol. 2005;62:1728–1733
  2. Ashburner J, Friston KJ. Why voxel-based morphometry should be used. Neuroimage. 2001;14:1238–1243
  3. Baron JC, Chételat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage. 2001;14:298–309
  4. Basso A, Capitani E, Laiacona M. Raven's coloured progressive matrices: normative values on 305 adult normal controls. Funct. Neurol. 1987;2:189–194
  5. Braak H, Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural. Transm. Suppl. 1998;53:127–140
  6. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. Rey–Osterrieth complex figure: normative values in an Italian population sample. Neurol. Sci. 2002;22:443–447
  7. Callen DJ, Black SE, Caldwell CB. Limbic system perfusion in Alzheimer's disease measured by MRI-coregistered HMPAO SPET. Eur. J. Nucl. Med. Mol. Imag. 2002;29:899–906
  8. Carlesimo GA, Sabbadini M, Fadda L, Caltagirone C. Word-list forgetting in young and elderly subjects: evidence for age-related decline in transferring information from transitory to permanent memory condition. Cortex. 1997;33:155–166
  9. Caroli A, Testa C, Geroldi C, Nobili F, Guerra UP, Bonetti M, et al. Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment. J. Neurol. 2007;254:1000–1008
  10. Caroli A, Testa C, Geroldi C, Nobili F, Barnden LR, Guerra UP, et al. Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment. J. Neurol. 2007;254:1698–1707
  11. Chételat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC. Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?. Neurology. 2003;60:1374–1377
  12. Chetelat G, Desgranges B, Landeau B, Mezenge F, Poline JB, de la Sayette V, et al. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease. Brain. 2008;131:60–71
  13. De Santi S, de Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A, et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol. Aging. 2001;22:529–539
  14. Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005;65:404–411
  15. DISPLAY (computer program). Brain Imaging Center—Montreal Neurological Institute. Available at: http://www.bic.mni.mcgill.ca/software
  16. Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur. J. Nucl. Med. Mol. Imag. 2003;30:1104–1113
  17. Drzezga A, Grimmer T, Riemenschneider M, Lautenschlager N, Siebner H, Alexopoulus P, et al. Prediction of individual clinical outcome in MCI by means of genetic assessment and 18F-FDG PET. J. Nucl. Med. 2005;46:1625–1632
  18. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, et al. Research criteria for subcortical vascular dementia in clinical trials. J. Neural. Transm. Suppl. 2000;59:23–30
  19. Filippini N, Scassellati C, Boccardi M, Pievani M, Testa C, Bocchio-Chiavetto L, et al. Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study. Eur. J. Hum. Genet. 2006;14:443–449
  20. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991;41:1006–1009
  21. Foster NL, Chase TN, Mansi L, Brooks R, Fedio P, Patronas NJ, et al. Cortical abnormalities in Alzheimer's disease. Ann. Neurol. 1984;16:649–654
  22. Friedland RP, Brun A, Budinger TF. Pathological and positron emission tomographic correlations in Alzheimer's disease. Lancet. 1985;26:228
  23. Frisoni GB, Testa C, Zorzan A, Sabattoli F, Beltramello A, Soininen H, et al. Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry. J. Neurol. Neurosurg. Psychiatry. 2002;73:657–664
  24. Frisoni GB, Testa C, Sabattoli F, Beltramello A, Soininen H, Laakso MP. Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study. J. Neurol. Neurosurg. Psychiatry. 2005;76:112–114
  25. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E. Trail making test: normative values from 287 normal adult controls. Ital. J. Neurol. Sci. 1996;17:305–309
  26. Good CD, Scahill RI, Fox NC, Ashburner J, Friston KJ, Chan D, et al. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias. Neuroimage. 2002;17:29–46
  27. Hamalainen A, Pihlajamaki M, Tanila H, Hanninen T, Niskanen E, Tervo S, et al. Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol. Aging. 2007;28:1889–1903
  28. Holman, B.L., Johnson, K.A., Gerada, B., Carvalho, P.A., Satlin, A., 1992. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J. Nucl. Med. 33, 181–185 (published erratum appears in J. Nucl. Med. 33, 484).
  29. Ibanez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology. 1998;50:1585–1593
  30. Ionov ID. Specific mechanism for blood inflow stimulation in brain area proe to Alzheimer's disease lesions. Int. J. Neurosci. 2007;117:1425–1442
  31. Ishii K, Sasaki H, Kono AK, Miyamoto N, Fukuda T, Mori E. Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies. Eur. J. Nucl. Med. Mol. Imag. 2005;32:959–963
  32. Johnson KA, Moran EK, Becker JA, Blacker D, Fischman AJ, Albert MS. Single photon emission computed tomography perfusion differences in mild cognitive impairment. J. Neurol. Neurosurg. Psychiatry. 2007;78:240–247
  33. Karas GB, Burton EJ, Rombouts SA, van Schijndel RA, O’Brien JT, Sceltens P, et al. A comprehensive study of gray matter loss in patients with Alzheimer's disease using optimized voxel-based morphometry. Neuroimage. 2003;18:895–907
  34. Kawachi T, Ishii K, Sakamoto S, Sasaki M, Mori T, Yamashita F, et al. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imag. 2006;33:801–809
  35. Kemp PM, Hoffmann SA, Holmes C, Bolt L, Ward T, Holmes RB, et al. The contribution of statistical parametric mapping in the assessment of precuneal and medial temporal lobe perfusion by 99mTc-HMPAO SPECT in mild Alzheimer's and Lewy body dementia. Nucl. Med. Commun. 2005;26:1099–1106
  36. Kircher TT, Weis S, Freymann K, Erb M, Jessen F, Grodd W, et al. Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding. J. Neurol. Neurosurg. Psychiatry. 2007;78:812–818
  37. Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ, et al. Antemortem diagnosis of frontotemporal lobar degeneration. Ann. Neurol. 2005;57:480–488
  38. Matsuda H, Kitayama N, Ohnishi T, Asada T, Nakano S, Sakamoto S, et al. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease. J. Nucl. Med. 2002;43:304–311
  39. Matsuda H, Kanetaka H, Ohnishi T, Asada T, Imabayashi E, Nakano S, et al. Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction. Eur. J. Nucl. Med. Mol. Imag. 2002;29:1502–1505
  40. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  41. McKeith IG, Ballard CG, Perry RH, Ince PG, O’Brien JT, Neill D, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology. 2000;54:1050–1058
  42. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 1997;42:85–94
  43. Mosconi L, Tsui WH, De Santi S, Li J, Rusinek H, Convit A, et al. Reduced hippocampal metabolism in MCI and AD. Neurology. 2005;64:1860–1867
  44. Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J. Nucl. Med. 2006;47:1778–1786
  45. Nestor PJ, Fryer TD, Smielewski P, Hodges JR. Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Ann. Neurol. 2003;54:343–351
  46. Novelli G, Papagno C, Capitani E, Laiacona M, Cappa SF, Vallar G. Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Arch. Psicol. Neurol. Psichiatr. 1986;47:477–506
  47. Pennanen C, Kivipelto M, Tuomainen S, Hartikainen P, Hanninen T, Laakso MP, et al. Hippocampus and entohrinal cortex in mild cognitive impairment and early AD. Neurobiol. Aging. 2004;25:303–310
  48. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999;56:303–308
  49. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch. Neurol. 2001;58:1985–1992
  50. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1997;1:385–401
  51. Riello R, Sabattoli F, Beltramello A, Bonetti M, Bono G, Falini A, et al. Brain volumes in healthy adults aged 40 years and over: a voxel based morphometry study. Aging Clin. Exp. Res. 2005;17:329–336
  52. Sharp P, Gemmell H, Cherryman G, Besson J, Crawford J, Smith F. Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia. J. Nucl. Med. 1986;27:761–768
  53. Shulman KI. Clock-drawing: is it the ideal cognitive screening test?. Int. J. Geriatr. Psychiatry. 2000;15:548–561
  54. Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neurologici. Ital. J. Neurol. Sci. 1987;8(suppl):47–50
  55. SPM. Statistical Parametric Mapping (computer program). Version 2. London: Functional Imaging Laboratory, 2002. Available at: http://www.fil.ion.ucl.ac.uk/spm/software/spm2.
  56. Tatsch K, Asenbaum S, Bartenstein P, Catafau A, Halldin C, Pilowsky LS, et al. European Association of Nuclear Medicine European Association of Nuclear Medicine procedure guidelines for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals. Eur. J. Nucl. Med. 2002;29:BP36–BP42

PII: S0197-4580(08)00148-6

doi: 10.1016/j.neurobiolaging.2008.05.001

Neurobiology of Aging
Volume 31, Issue 3 , Pages 387-397 , March 2010

Article Tools

* Image Usage & Resolution